Hepatitis B and liver transplantation
- PMID: 16231258
- DOI: 10.1086/497129
Hepatitis B and liver transplantation
Abstract
Liver transplantation is the treatment of choice for patients with liver failure secondary to chronic hepatitis B. However, liver transplantation is complicated by the risk of recurrent hepatitis B virus infection, which significantly impairs graft and patient survival. The main risk factor for the development of recurrent hepatitis B virus infection is the virus load at the time of transplantation. The development of antiviral medications, such as lamivudine and adefovir, and the implementation of effective prophylactic regimens using hepatitis B immune globulin have significantly improved the outcomes of hepatitis B after liver transplantation. However, current approaches continue to be hampered by the extremely high cost of treatment and the emergence of drug-resistant viral mutations. Ongoing studies are necessary to establish the most cost-effective approaches to prevent recurrent hepatitis B virus infection after liver transplantation.
Similar articles
-
Living donor liver transplantation for hepatitis B associated liver diseases: a 10-year experience in a single center.Hepatogastroenterology. 2008 Jul-Aug;55(85):1445-9. Hepatogastroenterology. 2008. PMID: 18795708
-
Advances in prophylaxis and treatment of recurrent hepatitis B after liver transplantation.Hepatobiliary Pancreat Dis Int. 2005 Nov;4(4):509-14. Hepatobiliary Pancreat Dis Int. 2005. PMID: 16286253 Review.
-
Management of hepatitis B in liver transplant recipients.J Viral Hepat. 2007 Nov;14 Suppl 1:37-44. doi: 10.1111/j.1365-2893.2007.00916.x. J Viral Hepat. 2007. PMID: 17958641 Review.
-
[Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].An Sist Sanit Navar. 2004;27 Suppl 2:91-101. An Sist Sanit Navar. 2004. PMID: 15381947 Review. Spanish.
-
Management of hepatitis B in liver transplant patients.J Clin Gastroenterol. 2005 Jan;39(1):58-63. J Clin Gastroenterol. 2005. PMID: 15599213 Review.
Cited by
-
Anti-HBs response to hepatitis B immunoglobulin prophylaxis in liver transplant recipients.Indian J Gastroenterol. 2014 May;33(3):226-30. doi: 10.1007/s12664-014-0457-z. Epub 2014 Apr 24. Indian J Gastroenterol. 2014. PMID: 24760685
-
Antiviral drug resistance: mechanisms and clinical implications.Infect Dis Clin North Am. 2010 Jun;24(2):413-37. doi: 10.1016/j.idc.2010.01.001. Infect Dis Clin North Am. 2010. Corrected and republished in: Infect Dis Clin North Am. 2010 Sep;24(3):809-33. doi: 10.1016/j.idc.2010.07.001. PMID: 20466277 Free PMC article. Corrected and republished. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical